AU2002343417A1 - Novel nucleic acids and polypeptides - Google Patents
Novel nucleic acids and polypeptidesInfo
- Publication number
- AU2002343417A1 AU2002343417A1 AU2002343417A AU2002343417A AU2002343417A1 AU 2002343417 A1 AU2002343417 A1 AU 2002343417A1 AU 2002343417 A AU2002343417 A AU 2002343417A AU 2002343417 A AU2002343417 A AU 2002343417A AU 2002343417 A1 AU2002343417 A1 AU 2002343417A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- nucleic acids
- novel nucleic
- novel
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32463101P | 2001-09-24 | 2001-09-24 | |
| US60/324,631 | 2001-09-24 | ||
| PCT/US2002/030474 WO2003029271A2 (en) | 2001-09-24 | 2002-09-24 | Novel nucleic acids and polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002343417A1 true AU2002343417A1 (en) | 2003-04-14 |
Family
ID=23264420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002343417A Abandoned AU2002343417A1 (en) | 2001-09-24 | 2002-09-24 | Novel nucleic acids and polypeptides |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1430112A4 (en) |
| AU (1) | AU2002343417A1 (en) |
| CA (1) | CA2461280A1 (en) |
| WO (1) | WO2003029271A2 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358353B2 (en) | 2000-08-22 | 2008-04-15 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| US6863892B2 (en) | 2000-08-22 | 2005-03-08 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| WO2002032962A2 (en) | 2000-10-20 | 2002-04-25 | Millennium Pharmaceuticals, Inc. | Compositions of human proteins and method of use thereof |
| US7309760B2 (en) * | 2001-04-17 | 2007-12-18 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| WO2002083866A2 (en) * | 2001-04-17 | 2002-10-24 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| FR2836687A1 (en) * | 2002-03-04 | 2003-09-05 | Gene Signal | GENES INVOLVED IN THE REGULATION OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR APPLICATIONS |
| JP2007504842A (en) * | 2003-05-29 | 2007-03-08 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | Compositions, kits and methods for identification, evaluation, prevention and treatment of breast cancer |
| GB0326197D0 (en) * | 2003-11-10 | 2003-12-17 | Randox Lab Ltd | Molecular marker |
| JPWO2005111213A1 (en) * | 2004-05-18 | 2008-03-27 | 学校法人 久留米大学 | Myc target gene mimitin |
| WO2006035741A1 (en) | 2004-09-29 | 2006-04-06 | Dainippon Sumitomo Pharma Co., Ltd. | Gene expressed specifically in es cells and utilization of the same |
| GB0526212D0 (en) * | 2005-12-22 | 2006-02-01 | Imp College Innovations Ltd | Methods |
| WO2008054534A2 (en) | 2006-05-11 | 2008-05-08 | Quark Pharmaceuticals, Inc. | Screening systems utilizing rtp801 |
| WO2007141796A2 (en) | 2006-06-09 | 2007-12-13 | Quark Pharmaceuticals, Inc. | Therapeutic uses of inhibitors of rtp801l |
| EP2371377A1 (en) * | 2007-02-09 | 2011-10-05 | Gene Signal International SA | Wound healing agent and composition |
| EP1980254A1 (en) * | 2007-04-13 | 2008-10-15 | Rijksuniversiteit te Groningen | Means and methods for counteracting protein aggregation |
| WO2009014450A1 (en) * | 2007-07-24 | 2009-01-29 | Sanare As | Novel peptides with anti-tumor activity |
| US8614311B2 (en) | 2007-12-12 | 2013-12-24 | Quark Pharmaceuticals, Inc. | RTP801L siRNA compounds and methods of use thereof |
| JP2013099253A (en) * | 2010-03-11 | 2013-05-23 | Intec Systems Institute Inc | Diagnostic marker for lung cancer or cervical cancer |
| US8288334B2 (en) * | 2010-06-14 | 2012-10-16 | Gene Signal International Sa | Peptides for wound healing |
| EP2595646B1 (en) * | 2010-07-21 | 2015-07-01 | Université de Montpellier | Bhlh proteins and their use as drugs |
| CN103209987B (en) | 2010-09-22 | 2017-06-06 | 艾丽奥斯生物制药有限公司 | substituted nucleotide analogs |
| EP2794630A4 (en) | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | Substituted phosphorothioate nucleotide analogs |
| WO2013142124A1 (en) | 2012-03-21 | 2013-09-26 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
| US8968742B2 (en) | 2012-08-23 | 2015-03-03 | Agensys, Inc. | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| LT3388075T (en) | 2015-03-27 | 2023-11-10 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003) |
| US20240218019A1 (en) * | 2021-04-06 | 2024-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions comprising mhc class i peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750345A (en) * | 1995-10-31 | 1998-05-12 | Evanston Hospital Corporation | Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
| US20020150898A1 (en) * | 2000-04-18 | 2002-10-17 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| US20030212257A1 (en) * | 2001-04-03 | 2003-11-13 | Spytek Kimberly A. | Novel human proteins, polynucleotides encoding them and methods of using the same |
-
2002
- 2002-09-24 WO PCT/US2002/030474 patent/WO2003029271A2/en not_active Ceased
- 2002-09-24 AU AU2002343417A patent/AU2002343417A1/en not_active Abandoned
- 2002-09-24 CA CA002461280A patent/CA2461280A1/en not_active Abandoned
- 2002-09-24 EP EP02780359A patent/EP1430112A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003029271A3 (en) | 2003-11-20 |
| WO2003029271A2 (en) | 2003-04-10 |
| EP1430112A4 (en) | 2005-06-15 |
| EP1430112A2 (en) | 2004-06-23 |
| CA2461280A1 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002366951A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002326877A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002314709A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001249251A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001243142A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001234944A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001290548A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001245280A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001233041A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001238347A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001296235A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001263006A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002343417A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001233017A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002368010A1 (en) | Novel nucleic acids and secreted polypeptides | |
| AU2002246502A1 (en) | Nucleic acids and polypeptides | |
| WO2003003984A8 (en) | Novel proteins and nucleic acids encoding same | |
| AU2001241511A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001250872A1 (en) | Novel nucleic acids and polypeptides | |
| AU2001292561A1 (en) | Nucleic acids and polypeptides | |
| AU2001277840A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002367815A1 (en) | Novel nucleic acids and secreted polypeptides | |
| EP1572995A3 (en) | Novel proteins and nucleic acids encoding same | |
| AU2002250419A1 (en) | Novel nucleic acids and polypeptides | |
| AU2002365189A1 (en) | P85-alpha nucleic acids, polypeptides and related methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |